0000912282-23-000135.txt : 20230620 0000912282-23-000135.hdr.sgml : 20230620 20230620082912 ACCESSION NUMBER: 0000912282-23-000135 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230425 FILED AS OF DATE: 20230620 DATE AS OF CHANGE: 20230620 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PYSZCZYMUKA GREG CENTRAL INDEX KEY: 0001952920 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38247 FILM NUMBER: 231023485 MAIL ADDRESS: STREET 1: C/O AYTU BIOPHARMA, INC. STREET 2: 373 INVERNESS PARKWAY, SUITE 206 CITY: ENGLEWOOD STATE: CO ZIP: 80112 FORMER NAME: FORMER CONFORMED NAME: PYSZCAYMUKA GREG DATE OF NAME CHANGE: 20221031 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AYTU BIOPHARMA, INC CENTRAL INDEX KEY: 0001385818 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 470883144 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 373 INVERNESS PARKWAY STREET 2: SUITE 206 CITY: ENGLEWOOD STATE: CO ZIP: 80112 BUSINESS PHONE: (720) 437-6580 MAIL ADDRESS: STREET 1: 373 INVERNESS PARKWAY STREET 2: SUITE 206 CITY: ENGLEWOOD STATE: CO ZIP: 80112 FORMER COMPANY: FORMER CONFORMED NAME: AYTU BIOSCIENCE, INC DATE OF NAME CHANGE: 20150609 FORMER COMPANY: FORMER CONFORMED NAME: AYTU BIOSCIENCE, INC. DATE OF NAME CHANGE: 20150609 FORMER COMPANY: FORMER CONFORMED NAME: Rosewind CORP DATE OF NAME CHANGE: 20070110 4 1 form4.xml X0407 4 2023-04-25 0001385818 AYTU BIOPHARMA, INC AYTU 0001952920 PYSZCZYMUKA GREG C/O AYTU BIOPHARMA, INC. 373 INVERNESS PARKWAY, SUITE 206 ENGLEWOOD CO 80112 true Chief Commerical Officer false Common Shares 2023-04-25 4 M 0 833 0 A 9935 D Restricted Stock Units 2023-04-25 4 M 0 833 0 D Common Shares 833 1667 D Reflects a 1:20 reverse stock split effected by the Issuer on January 4, 2023. Represents restricted stock units ("RSU"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs were granted on March 31, 2022, and vest as follows: One-third on March 31, 2023; 1/12th of the original grant quarterly thereafter through March 31, 2025. Settlement of vested RSUs will occur as soon as practicable following vesting. /s/ Mark Oki as attorney-in-fact for Greg Pyszczymuka 2023-06-19